Eye Journal
Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’ – (Eye 30, 766 (May 2016))
Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’ Eye 30, 766 (May 2016). doi:10.1038/eye.2016.2 Authors: D Călugăru & M Călugăru
Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ – (Eye 30, 766 (May 2016))
Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’ Eye 30, 766 (May 2016). doi:10.1038/eye.2016.6 Authors: T D Papakostas, D Vavvas, D Eliott & L A Kim
Is intraocular pressure the only important postoperative variable? The role of first day postoperative review after vitrectomy – (Eye 30, 767 (May 2016))
Is intraocular pressure the only important postoperative variable? The role of first day postoperative review after vitrectomy Eye 30, 767 (May 2016). doi:10.1038/eye.2016.4 Authors: K B Harshey & R Madhukumar
Intraocular pressure is not the only important postoperative variable following vitrectomy – (Eye 30, 768 (May 2016))
Intraocular pressure is not the only important postoperative variable following vitrectomy Eye 30, 768 (May 2016). doi:10.1038/eye.2016.5 Authors: P Alexander, L Michaels & R S Newsom
Simplified ab externo fixation technique to treat late dislocation of scleral-sutured polymethyl methacrylate intraocular lenses – (Eye 30, 769 (May 2016))
Simplified ab externo fixation technique to treat late dislocation of scleral-sutured polymethyl methacrylate intraocular lenses Eye 30, 769 (May 2016). doi:10.1038/eye.2016.52 Authors: J Lyu & P-q Zhao